Status:
COMPLETED
The Families Addressing Cancer Together Intervention for Parents With Cancer
Lead Sponsor:
UNC Lineberger Comprehensive Cancer Center
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
National Cancer Institute (NCI)
Conditions:
Neoplasms
Cancer
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
The proposed pilot randomized controlled trial will test the FACT (Families Addressing Cancer Together) intervention designed to improve parents' confidence and ability to talk about their cancer with...
Detailed Description
Parents with cancer are encouraged to be "honest and open" with their minor children about their illness. However, many lack access to professional support for their communication needs. Without this ...
Eligibility Criteria
Inclusion
- Informed consent reviewed and signed;
- Age equal to or above 18 years;
- Ability to understand and comply with study procedures;
- Able to complete all study measures and visits in English;
- Be a parent (defined as biological, adoptive, foster, or step-parent), kin caregiver (defined as a relative or someone with a significant emotional relationship who provides full-time care and nurturing of a child), or legal guardian of a child age 3 to 17 years of age who can speak and understand English;
- Have a diagnosis of Stage II-IV (or equivalent) invasive solid tumor not in surveillance or survivorship
Exclusion
- Unable to complete self-report instruments due to illiteracy, neurologic illness, inability to speak or read English, or other causes;
- Prior participation in the pilot trial or development and user testing protocol preliminary to this study;
- No current or expected contact with their child; or
- Existence of other co-morbid disease, which in the opinion of the investigator, prohibits participation in the protocol.
Key Trial Info
Start Date :
July 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 22 2023
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT05377749
Start Date
July 5 2022
End Date
February 22 2023
Last Update
May 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill
Chapel Hill, North Carolina, United States, 27599